Comparative efficacy of trovafloxacin in experimental endocarditis caused by ciprofloxacin-sensitive, methicillin-resistant Staphylococcus aureus

被引:6
作者
Kim, YS
Liu, QX
Chow, LL
Chambers, HF
Täuber, MG
机构
[1] San Francisco Gen Hosp, Infect Dis Lab, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA
关键词
D O I
10.1128/AAC.42.12.3325
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The new fluoroquinolone trovafloxacin was tested against a ciprofloxacin-sensitive, methicillin-resistant Staphylococcus aureus strain in the rabbit model of endocarditis. Trovafloxacin was more effective than van; comycin (CFU/g of vegetation, 2.65 +/- 1.87 versus 4.54 +/- 2.80 [mean +/- standard deviation]; P < 0.05) or ampicillin-sulbactam plus rifampin (4.9 +/- 1.1 CFU/g). The addition of ampicillin-sulbactam to trovafloxacin tended to reduce titers further.
引用
收藏
页码:3325 / 3327
页数:3
相关论文
共 31 条
[11]   ANTIBIOTIC-RESISTANCE IN STAPHYLOCOCCUS-AUREUS ISOLATED AT AN AUSTRALIAN HOSPITAL BETWEEN 1946 AND 1981 [J].
GILLESPIE, MT ;
MAY, JW ;
SKURRAY, RA .
JOURNAL OF MEDICAL MICROBIOLOGY, 1985, 19 (02) :137-147
[12]   IN-VIVO EFFICACY OF TROVAFLOXACIN (CP-99,219), A NEW QUINOLONE WITH EXTENDED ACTIVITIES AGAINST GRAM-POSITIVE PATHOGENS, STREPTOCOCCUS-PNEUMONIAE, AND BACTEROIDES-FRAGILIS [J].
GIRARD, AE ;
GIRARD, D ;
GOOTZ, TD ;
FAIELLA, JA ;
CIMOCHOWSKI, CR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (10) :2210-2216
[13]   EXPRESSION OF METHICILLIN RESISTANCE IN HETEROGENEOUS STRAINS OF STAPHYLOCOCCUS-AUREUS [J].
HARTMAN, BJ ;
TOMASZ, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (01) :85-92
[14]   Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility [J].
Hiramatsu, K ;
Hanaki, H ;
Ino, T ;
Yabuta, K ;
Oguri, T ;
Tenover, FC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) :135-136
[15]   ANTIMICROBIAL THERAPY OF EXPERIMENTAL ENTEROCOCCAL ENDOCARDITIS [J].
HOOK, EW ;
ROBERTS, RB ;
SANDE, MA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1975, 8 (05) :564-570
[16]  
JEVONS MP, 1961, BRIT MED J, V1, P124, DOI 10.1136/bmj.1.5219.124-a
[17]  
Kaatz GW, 1998, ANTIMICROB AGENTS CH, V42, P254
[18]   THE EMERGENCE OF RESISTANCE TO CIPROFLOXACIN DURING TREATMENT OF EXPERIMENTAL STAPHYLOCOCCUS-AUREUS ENDOCARDITIS [J].
KAATZ, GW ;
BARRIERE, SL ;
SCHABERG, DR ;
FEKETY, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1987, 20 (05) :753-758
[19]   Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae [J].
Kim, YS ;
Liu, QX ;
Chow, LL ;
Tauber, MG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1186-1189
[20]   SLOW RESPONSE TO VANCOMYCIN OR VANCOMYCIN PLUS RIFAMPIN IN METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS ENDOCARDITIS [J].
LEVINE, DP ;
FROMM, BS ;
REDDY, BR .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (09) :674-680